Oncology

Your Article Summary

See Latest Articles

Repeat prostate biopsy — when, where, and how
Urologic Oncology: Seminars and Original Investigations, 07/02/09

Presti JC - In a review of the indications and techniques in pts undergoing a repeat biopsy, it appears that in pts for whom repeat biopsies fail to identify cancer, yet clinical suspicion remains high, consideration for a saturation biopsy approach seems warranted.

• Pts who have a persistently elevated or a rising PSA level following a prior negative prostate biopsy can be a stressful situation for both urologist and pt.

• In pts with a prior negative biopsy, assessing the adequacy of the initial biopsy is important.
• F/T PSA is currently the most useful marker in predicting cancer on repeat biopsy, although newer markers, such as PCA3, are promising.
• Repeat biopsies should include a minimum of 14 cores, the 12 cores recommended for an initial biopsy and 2 additional cores obtained from the right and left anterior apex.

Today in Renal/Urologic...keeping you current

Receive free subspecialty "5-minute updates" via email

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09

Upfront, randomized, phase II trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma
Cancer, 11/03/09

Survivin as a prognostic marker for urothelial carcinoma of the bladder: A multicenter external validation study
Clinical Cancer Research, 11/17/09

See All of Renal/Urologic